Brainstorm Cell Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Biogen USD 6.29B 1.7M Mar/2026
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Cipla INR 3.82B 840.2M Mar/2026
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Cytokinetics USD 247.21M 868.77M Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
Grifols EUR 9.95B 722.93M Dec/2025
Halozyme Therapeutics USD 1.94B 206.73M Mar/2026
Mesoblast USD 66.02M 1.72M Dec/2025